Janus Henderson Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-33,963
| Closed | -$72.2K | – | 2572 |
|
|
2023
Q3 | $72.2K | Buy |
33,963
+9
| +0% | +$19 | ﹤0.01% | 2539 |
|
|
2023
Q2 | $161K | Buy |
33,954
+16
| +0% | +$76 | ﹤0.01% | 2503 |
|
|
2023
Q1 | $194K | Buy |
33,938
+18,519
| +120% | +$106K | ﹤0.01% | 2502 |
|
|
2022
Q4 | $156K | Sell |
15,419
-2,834,033
| -99% | -$28.6M | ﹤0.01% | 2245 |
|
|
2022
Q3 | $63.9M | Buy |
2,849,452
+1,413,939
| +98% | +$31.7M | 0.02% | 464 |
|
|
2022
Q2 | $35.6M | Sell |
1,435,513
-33,887
| -2% | -$840K | 0.02% | 456 |
|
|
2022
Q1 | $57M | Sell |
1,469,400
-73,204
| -5% | -$2.84M | 0.03% | 459 |
|
|
2021
Q4 | $90.3M | Sell |
1,542,604
-179,207
| -10% | -$10.5M | 0.04% | 376 |
|
|
2021
Q3 | $102M | Sell |
1,721,811
-104,173
| -6% | -$6.17M | 0.04% | 360 |
|
|
2021
Q2 | $158M | Sell |
1,825,984
-74,648
| -4% | -$6.48M | 0.07% | 282 |
|
|
2021
Q1 | $157M | Sell |
1,900,632
-644,936
| -25% | -$53.2M | 0.07% | 269 |
|
|
2020
Q4 | $231M | Sell |
2,545,568
-621,141
| -20% | -$56.5M | 0.11% | 197 |
|
|
2020
Q3 | $127M | Sell |
3,166,709
-492,685
| -13% | -$19.7M | 0.07% | 284 |
|
|
2020
Q2 | $126M | Buy |
3,659,394
+363,775
| +11% | +$12.5M | 0.07% | 271 |
|
|
2020
Q1 | $73.2M | Buy |
3,295,619
+3,285,567
| +32,686% | +$73M | 0.05% | 354 |
|
|
2019
Q4 | $197K | Buy |
+10,052
| New | +$197K | ﹤0.01% | 1394 |
|